Role of treatment on the development of secondary malignancies in patients with essential thrombocythemia-Reference-Cited by-同舟云学术

Role of treatment on the development of secondary malignancies in patients with essential thrombocythemia

Published:2017-05-23 Issue:6 Volume:6 Page:1233-1239
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Med

Author:

Santoro Cristina¹^ORCID,Sperduti Isabella²,Latagliata Roberto¹^ORCID,Baldacci Erminia¹,Anaclerico Barbara³,Avvisati Giuseppe⁴,Breccia Massimo¹,Buccisano Francesco⁵,Cedrone Michele³,Cimino Giuseppe⁶,De Gregoris Cinzia⁷,De Muro Marianna⁴,Di Veroli Ambra⁵^ORCID,Leonetti Crescenzi Sabrina⁸,Montanaro Marco⁷,Montefusco Enrico⁹,Porrini Raffaele⁹,Rago Angela⁶,Spadea Antonio¹⁰,Spirito Francesca¹¹,Villivà Nicoletta¹²,Andriani Alesssandro¹²,Alimena Giuliana¹,Mazzucconi Maria Gabriella¹

Affiliation:

1. Hematology, Department of Cellular Biotechnologies and Hematology; Sapienza University of Rome; Rome Italy

2. Biostatistical Unit; Regina Elena National Cancer Institute; Rome Italy

3. Hematology; San Giovanni Hospital; Rome Italy

4. Hematology; University Campus Biomedico; Rome Italy

5. Hematology; University Tor Vergata; Rome Italy

6. Hematology; Polo Universitario Pontino; Latina Italy

7. Hematology; Belcolle Hospital; Viterbo Italy

8. Hematology; Sandro Pertini Hospital; Rome Italy

9. Hematology; Sant'Andrea Hospital; Rome Italy

10. Hematology and Stem Cell Transplant Unit; Regina Elena National Cancer Unit; Rome Italy

11. Hematology; San Camillo Hospital; Rome Italy